Dr. Kun Ping Lu

Ph.D., Duke University
M.D., Fujian Medical University, China
Post-doctoral Scholar, The Salk Institute for Biological Studies

Office: MSB 340
E-mail: klu92@uwo.ca

Research Interests

Dr. Lu, in working with his long-term collaborator Dr. Xiao Zhen Zhou, has discovered a stress response enzyme called Pin1, whose dysregulation has the opposite impact on cancer and Alzheimer’s disease, major age-related diseases. Moreover, they have further identified Pin1 inhibitors to render aggressive cancer, such as pancreatic cancer, eradicable and created a new generation of innovative conformation-specific antibodies for early diagnosis and treatment of Alzheimer’s disease, traumatic brain injury, stroke, and sepsis. Their current interests are to further develop their novel Pin1-targeted therapeutics and diagnostics using cell cultures, animal models, and human tissues and translate them to the clinic for the early disease detection and treatment.


See list of publications in Google Scholar.